Authors:
SMITH IL
CHERRINGTON JM
JILES RE
FULLER MD
FREEMAN WR
SPECTOR SA
Citation: Il. Smith et al., HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES (VOL 176, PG 69, 1997), The Journal of infectious diseases, 177(4), 1998, pp. 1140-1141
Citation: Rm. Viani et al., HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PHENOTYPES IN CHILDREN WITH ADVANCED DISEASE TREATED WITH LONG-TERM ZALCITABINE, The Journal of infectious diseases, 177(3), 1998, pp. 565-570
Authors:
SMITH IL
TASKINTUNA I
RAHHAL FM
POWELL HC
AI E
MUELLER AJ
SPECTOR SA
FREEMAN WR
Citation: Il. Smith et al., CLINICAL FAILURE OF CMV RETINITIS WITH INTRAVITREAL CIDOFOVIR IS ASSOCIATED WITH ANTIVIRAL RESISTANCE, Archives of ophthalmology, 116(2), 1998, pp. 178-185
Authors:
TASKINTUNA I
SMITH IL
RAHHAL RM
POWELL HC
MUELLER AJ
AI E
JILES RE
CHERRINGTON JM
SPECTOR SA
FREEMAN WR
Citation: I. Taskintuna et al., CLINICAL RESISTANCE TO INTRAVITREAL CIDOFOVIR TREATMENT IN PATIENTS WITH AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, Investigative ophthalmology & visual science, 38(4), 1997, pp. 3419-3419
Authors:
SMITH IL
CHERRINGTON JM
JILES RE
FULLER MD
FREEMAN WR
SPECTOR SA
Citation: Il. Smith et al., HIGH-LEVEL RESISTANCE OF CYTOMEGALOVIRUS TO GANCICLOVIR IS ASSOCIATEDWITH ALTERATIONS IN BOTH THE UL97 AND DNA-POLYMERASE GENES, The Journal of infectious diseases, 176(1), 1997, pp. 69-77
Authors:
KNIGHT EV
KIMBALL JP
KEENAN CM
SMITH IL
WONG FA
BARRETT DS
DEMPSTER AM
LIEUALLEN WG
PANIGRAHI D
POWERS WJ
SZOT RJ
Citation: Ev. Knight et al., PRECLINICAL TOXICITY EVALUATION OF TEPOXALIN, A DUAL INHIBITOR OF CYCLOOXYGENASE AND 5-LIPOXYGENASE, IN SPRAGUE-DAWLEY RATS AND BEAGLE DOGS, Fundamental and applied toxicology, 33(1), 1996, pp. 38-48
Authors:
WALDMAN SA
VITOW C
OSBORNE B
GILLEN L
ARGENTIERI DC
WONG FA
SMITH IL
CHOW AT
MISITI J
BJORNSSON TD
Citation: Sa. Waldman et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF TEPOXALIN AFTER SINGLE ORAL DOSE ADMINISTRATION TO HEALTHY-VOLUNTEERS, Journal of clinical pharmacology, 36(5), 1996, pp. 462-468
Citation: Il. Smith et al., POLYRADICULOPATHY ASSOCIATED WITH GANCICLOVIR-RESISTANT CYTOMEGALOVIRUS IN AN AIDS PATIENT - PHENOTYPIC AND GENOTYPIC CHARACTERIZATION OF SEQUENTIAL VIRUS ISOLATES, The Journal of infectious diseases, 173(6), 1996, pp. 1481-1484
Authors:
RAFFA RB
CONNELLY CD
MARTINEZ RP
SCHUPSKY JJ
ARGENTIERI DC
SINGER MM
SMITH IL
Citation: Rb. Raffa et al., ANTINOCICEPTIVE EFFECTS OF A NOVEL DUAL CYCLOOXYGENASE 5-LIPOXYGENASEINHIBITOR (TEPOXALIN) AND ITS PRIMARY (CARBOXYLIC-ACID) METABOLITE (RWJ-20142) IN ACUTE TESTS IN MICE AND RATS, Drug development research, 36(2), 1995, pp. 81-90
Authors:
TATEBAYASHI M
NEYTS J
BESEN G
FLORESAGUILAR M
SMITH IL
WILEY CA
SPECTOR SA
BERGERONLYNN G
MAUDGAL PC
DECLERCQ E
GANGAN PA
CHAVEZ E
RUSSACK V
FREEMAN WR
Citation: M. Tatebayashi et al., ABSENCE OF INFECTIOUS RETINITIS AFTER INJECTION OF HUMAN CYTOMEGALOVIRUS INTO RABBIT EYES, The Journal of infectious diseases, 171(4), 1995, pp. 782-787
Authors:
WOLF DG
SMITH IL
LEE DJ
FREEMAN WR
FLORESAGUILAR M
SPECTOR SA
Citation: Dg. Wolf et al., MUTATIONS IN HUMAN CYTOMEGALOVIRUS UL97 GENE CONFER CLINICAL RESISTANCE TO GANCICLOVIR AND CAN BE DETECTED DIRECTLY IN PATIENT PLASMA, The Journal of clinical investigation, 95(1), 1995, pp. 257-263
Authors:
HUANG SM
BRUSSER L
CHIEN SC
SIMON D
SMITH IL
ABRAMS LS
LASSETER K
Citation: Sm. Huang et al., PHARMACOKINETICS AND BIOAVAILABILITY OF BEMORADAN, A LONG-ACTING INODILATOR IN HEALTHY-MALES, International journal of clinical pharmacology and therapeutics, 32(2), 1994, pp. 62-64
Authors:
LIU JJ
XIE B
SMITH IL
JOHNSTON CI
BUXTON BF
Citation: Jj. Liu et al., A STABLE LEUKOCYTE-DERIVED FACTOR INHIBITS PLATELET-AGGREGATION, Biochemical and biophysical research communications, 201(2), 1994, pp. 878-882
Authors:
GOODMAN MG
ABELS R
ANDERSON DW
CAPETOLA RJ
POPE BL
SMITH IL
Citation: Mg. Goodman et al., LOXORIBINE - A DISUBSTITUTED GUANOSINE WITH ADJUVANT ACTIVITY, AIDS research and human retroviruses, 9, 1993, pp. 190000095-190000095
Citation: Il. Smith et Ea. Smith, INHIBITION OF PAF-INDUCED ACTIVATION OF HUMAN PLATELETS BY VERAPAMIL, Thrombosis and haemostasis, 69(6), 1993, pp. 686-686
Citation: Il. Smith et al., MECHANISMS OF PURINERGIC RECEPTOR-OPERATED ION CHANNELS IN HUMAN PLATELETS, Thrombosis and haemostasis, 69(6), 1993, pp. 1343-1343